Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials | |
Zou, Yandun[1,2]; Hu, Chunling[2]; Ye, Wenhui[2]; Fan, Limei[2]; Xu, Likun[1]; Zhang, Aidong[1] | |
2015 | |
卷号 | 136期号:5页码:870 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4290975 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510630, Guangdong, Peoples R China 2.[2]Guangdong Women & Children Hosp, Internal Med, Guangzhou 510630, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Zou, Yandun[1,2],Hu, Chunling[2],Ye, Wenhui[2],et al. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials[J],2015,136(5):870. |
APA | Zou, Yandun[1,2],Hu, Chunling[2],Ye, Wenhui[2],Fan, Limei[2],Xu, Likun[1],&Zhang, Aidong[1].(2015).Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials.,136(5),870. |
MLA | Zou, Yandun[1,2],et al."Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials".136.5(2015):870. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论